- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 14.251 ↑ 0.62%
[as on 20 October, 2025]
NAV chart with SMA (Simple moving average) overlay
SMA (Simple Moving Average)
Returns
Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
---|
Kotak Healthcare Fund - Direct Plan - Growth Option | -2.48% | 0.62% | 1.57% | 0.41% | 1.06% | 1.99% | - | - | - | - |
Portfolio
Asset allocation
Equity | Debt | Realestate | Commodities | Cash & Equivalents |
---|
97.68% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
2.32% |
Equity
Name | Sector | Weight % |
---|
SUN PHARMACEUTICAL INDUSTRIES LTD. | Pharmaceuticals and Biotechnology | 13.05% |
Max Healthcare Institute Ltd. | Healthcare Services | 7.33% |
JB Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals and Biotechnology | 5.93% |
Cipla Ltd. | Pharmaceuticals and Biotechnology | 5.51% |
Divis Laboratories Ltd. | Pharmaceuticals and Biotechnology | 4.90% |
Apollo Hospitals Enterprise Ltd. | Healthcare Services | 4.23% |
Fortis Healthcare India Ltd | Healthcare Services | 4.18% |
Lupin Ltd. | Pharmaceuticals and Biotechnology | 3.91% |
JUBILANT PHARMOVA LIMITED | Pharmaceuticals and Biotechnology | 3.26% |
KRISHNA INSTITUTE OF MEDICAL | Healthcare Services | 3.02% |
Gland Pharma Limited | Pharmaceuticals and Biotechnology | 3.00% |
ASTER DM HEALTHCARE LTD | Healthcare Services | 2.90% |
ANTHEM BIOSCIENCES LTD | Pharmaceuticals and Biotechnology | 2.79% |
Dr.Reddy's Laboratories Ltd. | Pharmaceuticals and Biotechnology | 2.64% |
MANKIND PHARMA LTD | Pharmaceuticals and Biotechnology | 2.62% |
Alkem Laboratories Ltd. | Pharmaceuticals and Biotechnology | 2.57% |
Ami Organics Ltd | Pharmaceuticals and Biotechnology | 2.56% |
Glenmark Pharmaceuticals Ltd | Pharmaceuticals and Biotechnology | 2.40% |
Aurobindo Pharma Ltd. | Pharmaceuticals and Biotechnology | 2.36% |
Ajanta Pharma Ltd. | Pharmaceuticals and Biotechnology | 2.33% |
SAI LIFE SCIENCES LIMITED | Pharmaceuticals and Biotechnology | 2.23% |
LAXMI DENTAL LIMITED | Healthcare Equipment and Supplies | 2.10% |
Marksans Pharma Ltd | Pharmaceuticals and Biotechnology | 1.78% |
INNOVA CAPTABS LTD | Pharmaceuticals and Biotechnology | 1.75% |
Zydus Lifesciences Ltd. | Pharmaceuticals and Biotechnology | 1.69% |
Krsnaa Diagnostics Ltd | Healthcare Services | 1.63% |
ORCHID PHARMA LIMITED | Pharmaceuticals and Biotechnology | 1.51% |
YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD | Healthcare Services | 1.44% |
RAINBOW CHILDRENS MEDICARE LTD | Healthcare Services | 1.36% |
HIKAL LTD | Pharmaceuticals and Biotechnology | 0.70% |
Portfolio data is as on date 30 September, 2025
NAV (Net asset value) history
Kotak Healthcare Fund - Direct Plan - Growth Option - 30 days NAV history
Date | NAV |
---|
20 October, 2025 | 14.251 |
17 October, 2025 | 14.163 |
16 October, 2025 | 14.102 |
15 October, 2025 | 14.02 |
14 October, 2025 | 13.97 |
13 October, 2025 | 14.031 |
10 October, 2025 | 14.03 |
9 October, 2025 | 13.904 |
8 October, 2025 | 13.798 |
7 October, 2025 | 13.804 |
6 October, 2025 | 13.801 |
3 October, 2025 | 13.635 |
1 October, 2025 | 13.67 |
30 September, 2025 | 13.523 |
29 September, 2025 | 13.536 |
26 September, 2025 | 13.549 |
25 September, 2025 | 13.794 |
24 September, 2025 | 13.902 |
23 September, 2025 | 14.019 |
22 September, 2025 | 14.071 |
19 September, 2025 | 14.193 |
18 September, 2025 | 14.16 |
17 September, 2025 | 14.067 |
16 September, 2025 | 14.062 |
15 September, 2025 | 14.01 |
12 September, 2025 | 14.057 |
11 September, 2025 | 14.037 |
10 September, 2025 | 14.01 |
9 September, 2025 | 13.935 |
8 September, 2025 | 13.849 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Kotak Healthcare Fund - Direct Plan - Growth Option?
The latest NAV of Kotak Healthcare Fund - Direct Plan - Growth Option is 14.251 as on 20 October, 2025.
What are YTD (year to date) returns of Kotak Healthcare Fund - Direct Plan - Growth Option?
The YTD (year to date) returns of Kotak Healthcare Fund - Direct Plan - Growth Option are -2.48% as on 20 October, 2025.
What are 1 year returns of Kotak Healthcare Fund - Direct Plan - Growth Option?
The 1 year returns of Kotak Healthcare Fund - Direct Plan - Growth Option are 1.99% as on 20 October, 2025.